Question 1

What is the catalog number for Jeko-1/iRFP stable cell line?

Accepted Answer

The catalog number for Jeko-1/iRFP stable cell line is CL-1789.

Question 2

What sizes are available for Jeko-1/iRFP stable cell line?

Accepted Answer

Jeko-1/iRFP stable cell line is available in the following size(s): 1 Vial.

Question 3

Is Jeko-1/iRFP stable cell line in stock?

Accepted Answer

Jeko-1/iRFP stable cell line is currently made to order / not held in immediate stock. Contact us for lead time.

Question 4

What is Jeko-1/iRFP stable cell line used for?

Accepted Answer

Jeko-1/iRFP cells are derived from the human precursor B cell lymphoblast cell line Jeko-1 by stably integration of a constitutive miRFP670 stably expression construct. Jeko-1 cells stably express CD19, are ideal for testing CAR T cell or other immunotherapies. Jeko-1/iRFP cells stably express miRFP

Question 5

Is this product species cross-reactive?

Accepted Answer

Cross-reactivity data, based on available testing, is listed under the reactivity section of the datasheet. Contact us if you need reactivity confirmed for a species not listed.

Question 6

Is there an additional fee for hazardous or dry ice shipping of this product?

Accepted Answer

Yes, if this product requires dry ice or is classed as hazardous for transport, the additional fee will be explicitly shown in your quotation before you confirm the order, so there are no surprise charges later.

Question 7

How many freeze-thaw cycles can this product tolerate?

Accepted Answer

We recommend aliquoting the product upon receipt to avoid repeated freeze-thaw cycles, which can reduce activity and stability. This is your responsibility once the product has been delivered.

Jeko-1/iRFP stable cell line

Product Specifications

Frequently Asked Questions

Explore Other Products

Mouse Cryba2 activation kit by CRISPRa

Cystatin A (CPTC-CSTA-1), CF640R conjugate, 0.1mg/mL

PPIAL4G (NM_001123068) Human Over-expression Lysate

TRAF4 (NM_004295) Human Recombinant Protein

NKX6.1 (Marker for Pancreatic and Duodenal Neuroendocrine Tumors) (NKX61/2561), CF488A conjugate, 0.1mg/mL

CD79a (IGA/764), 0.2mg/mL